Written questions by Stafford.

Whether he will publish any correspondence sent to EU officials proposing a data sharing agreement to access doctor malpractice data from the IMI system.

Government officials recently met with the United Kingdom professional regulator of doctors, the General Medical Council (GMC), to discuss what more could be done to strengthen and improve the exchange of information between the GMC and other UK healthcare professional regulators, and their European Union counterparts. We are committed to a constructive relationship with Europe and will continue to identify areas where closer collaboration is mutually beneficial, including improving information sharing and strengthening health security. The UK has not had recent discussions on the Internal Market Information system with the EU, although the Department is exploring options to further support UK healthcare professional regulators to unblock data sharing barriers.

What steps his Department has taken to negotiate a data sharing agreement with the EU to access doctor malpractice data held on the Internal Market Information system.

Government officials recently met with the United Kingdom professional regulator of doctors, the General Medical Council (GMC), to discuss what more could be done to strengthen and improve the exchange of information between the GMC and other UK healthcare professional regulators, and their European Union counterparts. We are committed to a constructive relationship with Europe and will continue to identify areas where closer collaboration is mutually beneficial, including improving information sharing and strengthening health security. The UK has not had recent discussions on the Internal Market Information system with the EU, although the Department is exploring options to further support UK healthcare professional regulators to unblock data sharing barriers.

What steps his Department is taking to (a) increase survival rates from out-of-hospital cardiac arrests and (b) increase the availability of defibrillators in Farnham and Bordon.

In order to increase survival rates from out-of-hospital cardiac arrest NHS England has worked in partnership with St John’s Ambulance and others to increase access to cardiopulmonary resuscitation (CPR) training. Local ambulance trusts, charities, including St John’s Ambulance and the British Heart Foundation, and private providers deliver CPR training and training on the use of defibrillators both in the community and in schools, under the Restart a Heart programme.The Government’s position is that local communities, including in Farnham and Bordon, are best placed to make decisions about procuring, locating, and maintaining automated external defibrillators (AEDs). Over 110,000 defibrillators are registered in the United Kingdom on The Circuit, the independent AED database. Over 30,000 of these have been added in the past two years, many as a result of local community led action.It is not uncommon for charities supplying defibrillators through a fund to require those defibrillators to be registered on The Circuit. Defibrillator charities also promote The Circuit on their website.

What steps his Department is taking to encourage community organisations, schools, and workplaces in Farnham and Bordon to register their Automated External Defibrillators on the Circuit Defibrillator Network.

In order to increase survival rates from out-of-hospital cardiac arrest NHS England has worked in partnership with St John’s Ambulance and others to increase access to cardiopulmonary resuscitation (CPR) training. Local ambulance trusts, charities, including St John’s Ambulance and the British Heart Foundation, and private providers deliver CPR training and training on the use of defibrillators both in the community and in schools, under the Restart a Heart programme.The Government’s position is that local communities, including in Farnham and Bordon, are best placed to make decisions about procuring, locating, and maintaining automated external defibrillators (AEDs). Over 110,000 defibrillators are registered in the United Kingdom on The Circuit, the independent AED database. Over 30,000 of these have been added in the past two years, many as a result of local community led action.It is not uncommon for charities supplying defibrillators through a fund to require those defibrillators to be registered on The Circuit. Defibrillator charities also promote The Circuit on their website.

Whether mandatory alcohol labelling requirements will apply to both on‑trade and off‑trade settings.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

With reference to the National Cancer Plan for England, if he will set out the formats for mandatory health warnings on alcohol labels that his Department is considering, including whether these include text‑only warnings, cancer‑specific messaging, imagery, rotating labels, and pictograms.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

What assessment he has made of the potential impact of proposed mandatory alcohol labelling reforms on producers, small businesses, supply chains and exporters.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

What plans his Department has to develop a definition of health warning for the purposes of alcohol labelling reforms.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

What assessment her Department has made of the potential merits of mandatory alcohol health warnings for regulatory alignment with the EU, Ireland, and other trading partners.

In both the Fit for the Future: 10-Year Health Plan for England and the National Cancer Plan for England, the Government committed to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials have recently completed a round of stakeholder engagement regarding the policy. We are working at pace to review all available and emerging evidence.This work will inform the development assessment of policy options that will be set out in formal consultation which we are working towards opening in late 2026. International alignment will be considered as part of the process, taking into account the outcome of the Sanitary and Phytosanitary (Agri-Food) Agreement negotiations with the European Union.

To ask the Secretary of State for Health and Social Care when he plans to publish draft designs for mandatory alcohol health warnings; and what his planned timetable is for (a) consultation on and (b) the implementation of those warnings.

In Fit for the Future: 10 Year Health Plan for England, the Government committed to strengthening and expanding existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages. The plan can be accessed online at the following link:https://www.gov.uk/government/publications/10-year-health-plan-for-england-fit-for-the-futureThe Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and businesses to respond to. The consultation will be prepared in line with guidance on seeking collective agreement across Government departments.

Including for long‑lifecycle products such as wine.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

Whether his Department has assessed the potential merits of using QR codes or digital labelling to supplement mandatory on‑label health warnings.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are currently exploring and assessing the potential options for and impacts of delivering this policy commitment, which includes reviewing all available and emerging evidence, and considering stakeholder feedback, having just completed a round of stakeholder engagement.The Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and business to respond to.

What steps her Department is taking to ensure industry and civil society are prepared for the forthcoming consultation on mandatory alcohol labelling; and whether draft policy scenarios will be shared with Parliament ahead of its launch of a consultation.

In Fit for the Future: 10 Year Health Plan for England, the Government committed to strengthening and expanding existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages. The plan can be accessed online at the following link:https://www.gov.uk/government/publications/10-year-health-plan-for-england-fit-for-the-futureThe Department is working towards opening a consultation in late 2026, setting out the options under consideration, for the public and businesses to respond to. The consultation will be prepared in line with guidance on seeking collective agreement across Government departments.

With reference to the National Cancer Plan for England, what empirical evidence his Department is reviewing to inform the design of mandatory alcohol health warnings, including those used in South Korea and Ireland.

The recently published National Cancer Plan reiterated the commitment made in Fit for the Future: 10-Year Health Plan for England, to strengthen and expand on existing voluntary guidelines for alcohol labelling by introducing a mandatory requirement for alcoholic drinks to display consistent nutritional information and health warning messages.Department officials are working at pace to review all available and emerging evidence. This includes data from a broad range of countries and engaging with a wide range of national and international stakeholders, including stakeholder feedback provided at and after the recent roundtables.

What assessment he has made of the potential merits of reinstating the Life Sciences Council with representation from the generic and biosimilar medicines industry.

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there is an opportunity for the National Health Service to save £1 billion over five years through biosimilars uptake, delivering value for patients and the NHS. The Life Sciences Council is an important forum that brings together senior industry and Government leaders to shape the sector’s future. The Government remains committed to this partnership and is looking to convene the council in due course.Medicines UK and its members are represented on the Single National Formulary Industry Task and Finish Group. In addition, the Government is working to convene further task and finish groups to drive forward defined areas of the Life Sciences Sector Plan, including in the generic and biosimilars space. These groups will direct focused ministerial and official attention toward a clear set of priorities and will work closely with industry to deliver tangible progress within a set timeframe.

When the Government plans to establish a task and finish group to oversee delivery of the Life Sciences Sector Plan as it relates to generic and biosimilar medicines.

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there is an opportunity for the National Health Service to save £1 billion over five years through biosimilars uptake, delivering value for patients and the NHS. The Life Sciences Council is an important forum that brings together senior industry and Government leaders to shape the sector’s future. The Government remains committed to this partnership and is looking to convene the council in due course.Medicines UK and its members are represented on the Single National Formulary Industry Task and Finish Group. In addition, the Government is working to convene further task and finish groups to drive forward defined areas of the Life Sciences Sector Plan, including in the generic and biosimilars space. These groups will direct focused ministerial and official attention toward a clear set of priorities and will work closely with industry to deliver tangible progress within a set timeframe.

What consideration has been given to the role of the generic and biosimilar medicines sector in shaping life sciences policy, in the context of it supplying around 85% of NHS prescription drugs by volume.

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there is an opportunity for the National Health Service to save £1 billion over five years through biosimilars uptake, delivering value for patients and the NHS. The Life Sciences Council is an important forum that brings together senior industry and Government leaders to shape the sector’s future. The Government remains committed to this partnership and is looking to convene the council in due course.Medicines UK and its members are represented on the Single National Formulary Industry Task and Finish Group. In addition, the Government is working to convene further task and finish groups to drive forward defined areas of the Life Sciences Sector Plan, including in the generic and biosimilars space. These groups will direct focused ministerial and official attention toward a clear set of priorities and will work closely with industry to deliver tangible progress within a set timeframe.

What steps his Department is taking to help increase the uptake of generic and biosimilar medicines to meet the objectives set out in the Government’s Life Sciences Sector Plan.

The United Kingdom is a global leader in adopting biosimilar and generic medicines, which deliver major National Health Service savings and expand patient access to effective treatments sooner. We are working with the Medicines and Healthcare products Regulatory Agency, the National Institute for Health and Care Excellence (NICE), and NHS England to understand forthcoming biosimilars and to ensure they reach the frontline efficiently. Through NHS England’s Best Value Biologicals Framework, clinicians start patients on the most cost‑effective biologics where appropriate, and switches are made swiftly and safely. This has already delivered £1.2 billion in savings over the past three years. As set out in the 10‑Year Health Plan and Life Sciences Sector Plan, we are streamlining regulation, improving procurement, and reducing variation in uptake. NICE’s whole‑lifecycle approach ensures clinical pathways are regularly reviewed so that patients benefit as soon as cost‑effective generics and biosimilars become available, as seen in recent cancer treatments. These actions support timely access to effective off‑patent medicines and a sustainable, competitive market for the NHS.

Whether the Government plans to reinstate the Life Sciences Council.

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. The sector is forecast to grow by £41 billion and create 100,000 jobs by 2030, supporting our ambition to lead Europe in life sciences by 2030.The Life Sciences Council is an important forum that brings together senior industry and Government leaders to shape the sector’s future. The Government remains committed to this partnership and is looking to convene the council in due course.

What assessment his Department has made of the potential impact of a respiratory modern service framework on winter pressures on the NHS.

Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and then identify the best evidenced interventions and the support for delivery. Early priorities will include cardiovascular disease, severe mental illness, and the first ever service framework for frailty and dementia.The Government will consider other long-term conditions for future waves of modern service frameworks, including respiratory conditions. The criteria for determining other conditions for future modern service frameworks will be based on where there is potential for rapid and significant improvements in quality of care and productivity. There has not, therefore, been a specific assessment made in relation to winter pressures.NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the National Health Service this winter. Further details of the actions being taken to reduce demand on acute services during winter is available at the following link:https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/